On : 26 june 2025
• As of 2023, the global bovine medicine and vaccines market was valued at USD 2,863 million. Forecasts suggest significant growth, with the market expected to reach USD 4,675.16 million by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 5.60% over the forecast period. This robust growth is indicative of rising awareness around animal health, increasing livestock populations, and supportive government initiatives.
Email: help@intelmarketresearch.com +91
• The high cost of veterinary medications and vaccines, particularly in low- and middleincome nations, is one of the main factors impeding market expansion despite the rising demand for bovine health solutions. The cost and availability of high-quality veterinary care are major issues for many small-scale or subsistence farmers in rural areas of South Asia, Latin America, and Africa. The situation is made worse by the absence of cold chain infrastructure and qualified veterinary specialists, which restricts the scope of immunization campaigns and the prompt treatment of infections.According to FAO data, more than 60% of cattle farmers in nations like Bangladesh and Ethiopia have little to no access to official veterinary services. Farmers are ultimately deterred from investing in formal health solutions by this service delivery gap, which frequently leads to delayed disease diagnosis, inadequate treatment, and recurrent outbreaks. This problem could seriously impede market penetration in high-potential but underserved areas unless costeffective delivery models and public-private partnerships are expanded.
Email:
•Medicine
• Antibiotics
• Anti-inflammatories
• Nutritional Supplements
• Others
•Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Others
• Veterinary Hospitals and Clinics
• Farms and Livestock Owners
• Veterinary Research Institutes
• Retail Pharmacies and Drug Stores
Email: help@intelmarketresearch.com
Jinyu Group
Cavet Bio
CAHIC
Tecon Group
Shen Lian
Biogenesis Bagú
BIGVET Biotech
Indian Immunologicals
